<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T02:06:32Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/219974" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/219974</identifier><datestamp>2025-12-05T09:56:11Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478920</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Pre- to post-contrast breast MRI synthesis for enhanced tumour segmentation</dc:title>
   <dc:creator>Osuala, Richard</dc:creator>
   <dc:creator>Joshi, Smriti</dc:creator>
   <dc:creator>Tsirikoglou, Apostolia</dc:creator>
   <dc:creator>Garrucho, Lidia</dc:creator>
   <dc:creator>López Pinaya, Walter Hugo</dc:creator>
   <dc:creator>Díaz, Oliver</dc:creator>
   <dc:creator>Lekadir, Karim, 1977-</dc:creator>
   <dc:subject>Càncer de mama</dc:subject>
   <dc:subject>Aprenentatge automàtic</dc:subject>
   <dc:subject>Substàncies de contrast</dc:subject>
   <dc:subject>Breast cancer</dc:subject>
   <dc:subject>Machine learning</dc:subject>
   <dc:subject>Contrast media (Diagnostic imaging)</dc:subject>
   <dc:description>Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic&#xd;
contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccu-&#xd;
mulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic&#xd;
contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding&#xd;
first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we&#xd;
introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic&#xd;
data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the&#xd;
generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task&#xd;
of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in&#xd;
enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available&#xd;
at https://github.com/RichardObi/pre_post_synthesis.</dc:description>
   <dc:date>2025-03-25T10:21:23Z</dc:date>
   <dc:date>2025-03-25T10:21:23Z</dc:date>
   <dc:date>2024</dc:date>
   <dc:type>info:eu-repo/semantics/conferenceObject</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:identifier>https://hdl.handle.net/2445/219974</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Versió postprint de la comunicació publicada a: https://doi.org/10.1117/12.3006961</dc:relation>
   <dc:relation>Comunicació a: Proc. SPIE 12926, Medical Imaging 2024: Image Processing, 129260Y (2 April 2024)</dc:relation>
   <dc:relation>Proceedings SPIE</dc:relation>
   <dc:relation>12926</dc:relation>
   <dc:relation>https://doi.org/10.1117/12.3006961</dc:relation>
   <dc:rights>(c) SPIE, 2024</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>12 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>SPIE</dc:publisher>
   <dc:source>Comunicacions a congressos  (Matemàtiques i Informàtica)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>